Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 10-nov-2026 · last seen 10-nov-2026

Lysergic Acid Diethylamide (LSD)

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-10-22 — Lysergic acid diethylamide extends lifespan in Caenorhabditis elegans.: [animal-model] A C. elegans study reported lifespan extension of up to 17.6% with chronic or transient early-adulthood nanomolar LSD exposure, implicating serotonergic GPCR signaling and caloric restriction-like nutrient-sensing pathways; this finding does not establish human longevity benefits. [animal-model] (novelty: 3)

Open questions

Related

Contributing findings

pubmed preclinical animal-model
Lysergic acid diethylamide extends lifespan in Caenorhabditis elegans.
22-oct-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18